Microcapsules and methods

By using microcapsule shell materials of plant protein and polysaccharides, combined with ion crosslinking technology, the problem of poor surface feeling of existing microcapsules is solved, and the softness and resilience of the fabric is improved, providing better feel and protection. Effect.

CN119072297APending Publication Date: 2024-12-03UNILEVER IP HLDG BV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202380035941.6
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2022-05-31
Filing Date
2023-05-12
Publication Date
2024-12-03

AI Technical Summary

Technical Problem

Existing microcapsules feel poorly when dealing with surfaces, making it difficult to meet consumers' demand for softness and resilience.

Method used

Use plant proteins and polysaccharides as microcapsules shell materials, and prepare microcapsules through ionic crosslinking or hydrogen bonding methods to avoid chemical covalent crosslinking, use fragrances as core materials, and add deposition additives to the shell to improve the feel and resilience.

Benefits of technology

The relative feel value and drape resilience of the microcapsules are significantly improved, providing better fabric softness and protection.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0005098525290000101
    Figure BDA0005098525290000101
  • Figure BDA0005098525290000102
    Figure BDA0005098525290000102
  • Figure BDA0005098525290000111
    Figure BDA0005098525290000111
Patent Text Reader

Abstract

The present invention relates to a microcapsule, wherein the microcapsule has a core and a shell; the core comprises a core material selected from perfumes; the shell comprises vegetable protein and polysaccharide, and the polysaccharide is selected from pectin, natural or chemical modified cellulose, xanthan gum, konjac gum, xyloglucan, guar gum, Tala gum, locust bean gum, inulin, gel polysaccharide gum, diding gum, alginate, gellan gum and carrageenan; the invention also relates to a method for producing microcapsules according to the invention, wherein the method does not involve chemical covalent crosslinking.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to microcapsules and methods of producing the same. Background Art

[0002] Microcapsules are used in various applications to deliver active materials to substrates. Microcapsules are known to provide various benefits, such as delaying the release of active substances or protecting active substances from other ingredients in various compositions. Conventional microcapsules typically have a microcapsule wall formed from a synthetic polymer such as a melamine formaldehyde polymer or a polyacrylate polymer.

[0003] WO 2020 / 131879A1 discloses pea protein microcapsules having covalently cross-linked polyisocyanates in the shell.

[0004] There remains a need for improved microcapsules and, in particular, a need for improved feel of surfaces treated with microcapsules. Summary of the invention

[0005] It has been found that surfaces treated with the microcapsules of the present invention have an improved perception by the consumer.

[0006] Therefore, in a first aspect of the present invention, a microcapsule is provided, wherein the microcapsule has a core and a shell; the core comprises a core material selected from spices; the shell comprises a plant protein and a polysaccharide, wherein the polysaccharide is selected from: pectin, natural or chemically modified cellulose, xanthan gum, konjac gum, xyloglucan, guar gum, tara gum, locust bean gum, inulin, curdlan gum, diutan gum, alginate, gellan gum and carrageenan.

[0007] Preferably, the microcapsules are biodegradable.

[0008] Preferably, the microcapsules encapsulate a biodegradable fragrance.

[0009] Preferably, the protein used in the shell of the microcapsules is selected from pea protein.

[0010] Preferably, the polysaccharide used in the shell of the microcapsule is selected from alginate, gellan gum, carrageenan, more preferably, the polysaccharide is alginate.

[0011] Preferably, the microcapsules comprise 1 to 80% by weight, preferably 2 to 70% by weight, of shell material.

[0012] Preferably, the microcapsules further comprise a deposition aid attached to the shell of the microcapsules.

[0013] In a second aspect, the present invention provides a method for preparing microcapsules according to the first aspect of the present invention, wherein the method does not involve chemical covalent cross-linking.

[0014] Preferably, the method is selected from ionic cross-linking, charged polymer cross-linking or hydrogen bonding, more preferably ionic cross-linking. DETAILED DESCRIPTION

[0015] These and other aspects, features and advantages will become apparent to those skilled in the art by reading the following detailed description and the appended claims. For the avoidance of doubt, any feature of one aspect of the present invention may be used in any other aspect of the present invention. The word "comprising" is intended to mean "including", but not necessarily "consisting of" or "composed of". In other words, the listed steps or options need not be exhaustive.

[0016] It should be noted that the examples given in the following description are intended to illustrate the present invention, and are not intended to limit the present invention to these examples themselves. Similarly, unless otherwise stated, all percentages are weight / weight percentages. Except in the operating examples and comparative examples, or where otherwise clearly indicated, all numerals representing the amount or reaction conditions of the material, the physical properties of the material and / or the uses in this specification should be understood to be modified by the word "about". The numerical range expressed in the form of "from x to y" should be understood to include x and y. When multiple preferred ranges are described in the format of "from x to y" for a particular feature, it should be understood that all ranges combining different endpoints are also covered.

[0017] A microcapsule composition is understood herein to mean a composition comprising microcapsules added to a further composition.The microcapsule composition may comprise microcapsules alone or may be in the form of a slurry comprising microcapsules.

[0018] Microcapsules are understood in this context to mean microcapsules (wall and core), ie without solvent or slurry.

[0019] The microcapsules can be provided simply as microcapsules, but are preferably provided as a microcapsule composition comprising microcapsules in a slurry. The microcapsules comprise a microcapsule core and a microcapsule wall encapsulating the core, the microcapsule core comprising a core material selected from a fragrance and / or a benefit agent. The microcapsule wall comprises a wall polymer and optionally but preferably a crosslinking agent. Typically, the microcapsules comprise 10 wt % to 98 wt % of the core material, 1 wt % to 40 wt % of the shell material comprising a protein and a polysaccharide, and optionally 0.2 wt % to 6 wt % of a crosslinking agent.

[0020] Microcapsules can be prepared by any suitable method, including those exemplary methods described herein.

[0021] As used herein, the terms "fragrance" and "perfume" are used interchangeably to refer to the same material.

[0022] Biodegradability

[0023] Where materials used herein are referred to as biodegradable, it is meant that they meet the requirements for biodegradability as defined in the OECD. Specifically, the biodegradability of the materials is tested according to OECD standard 301F.

[0024] Microcapsules

[0025] Microcapsules can be considered as capsules encapsulating active substances. Microcapsules used herein have a core material selected from fragrances and / or benefit agents, and a shell comprising proteins and polysaccharides.

[0026] Microcapsule shell material

[0027] The microcapsule shell comprises a vegetable protein and a polysaccharide polymer. The protein and polysaccharide can be treated by various methods to provide derivatives, including but not limited to hydrolysis, condensation, functionalization such as ethoxylation, cross-linking, etc. The microcapsule wall material is preferably in an aqueous solution. The microcapsule shell preferably comprises 20% to 100% by weight, more preferably 30% to 98% by weight, more preferably 35% to 95% by weight, and most preferably 65% ​​to 90% by weight of protein and polysaccharide based on the weight of the microcapsule shell.

[0028] As conventional in the art, a "polypeptide" or "protein" is a linear organic polymer consisting of amino acid residues that are bonded together in a chain to form part (or all) of a protein molecule. As used herein, "polypeptide" or "protein" refers to a natural polypeptide, a polypeptide derivative and / or a modified polypeptide. A polypeptide may exhibit an average molecular weight of 1,000 Da to 40,000,000 Da, preferably greater than 10,000 Da, more preferably 100,000 Da, most preferably greater than 1,000,000 Da and preferably less than 3,000,000 Da.

[0029] Proteins suitable for use in the present invention include plant proteins.

[0030] Suitable preferred proteins include proteins selected from chickpea, pea protein, potato protein, brown rice protein, white rice protein, wheat protein, barley protein, pumpkin seed protein, oat protein, almond protein and combinations thereof. This includes derivatives of the above proteins.

[0031] Preferred protein classes are vegetable proteins. Vegetable proteins are proteins that accumulate in various plant tissues. Preferred vegetable proteins can be divided into two categories: seed or grain proteins and plant proteins. Seed / grain proteins are a group of proteins that accumulate to high levels in seeds / grains during the later stages of seed / grain development, while plant proteins are proteins that accumulate in vegetative tissues such as leaves, stems, and (depending on the plant species) tubers.

[0032] Preferred examples of seed / cereal / legume storage proteins are proteins from soy, lupin, pea, chickpea, alfalfa, bean, lentil and lentil; from oilseed plants such as rapeseed, cottonseed and sunflower; from cereals such as wheat, corn, barley, malt, oats, rye and rice (e.g., brown rice protein), or combinations thereof.

[0033] Preferred examples of vegetable proteins are in the form of protein from potato or sweet potato tubers.

[0034] The term vegetable protein is intended to include vegetable protein isolates, vegetable protein concentrates, or combinations thereof. Vegetable protein isolates and concentrates are generally understood to be composed of several proteins. For example, pea protein isolates and concentrates may include legumin, pea globulin, and convicilin protein. Similarly, brown rice protein isolates may include albumin, globulin, and gluten. The term "vegetable protein" is also intended to include partially or completely modified or denatured plant storage proteins. Individual polypeptides (e.g., legumin, pea globulin, convicilin, albumin, globulin, or gluten) may also be used to prepare microcapsules of the present invention.

[0035] Native proteins may be preferred. However, the method may include the step of denaturing the protein by pH adjustment, heating or adding a chaotropic agent to the oil-in-water emulsion or to the protein prior to adding to the oil-in-water emulsion.

[0036] Denaturation is a process in which a protein (polypeptide) loses its quaternary, tertiary and secondary structures present in its native state by applying denaturing conditions. During the denaturation process, the protein changes its conformational structure by unfolding, thereby making amine and hydroxyl groups available for cross-linking to form the microcapsule wall. Exemplary conditions for protein denaturation include, but are not limited to, radiation, exposure to heat or cold, pH changes with acids or bases, exposure to denaturants such as detergents, inorganic salts, organic solvents (e.g., alcohols, ethyl acetate and chloroform), urea or other chaotropic agents, or mechanical stress (including shear). Exemplary chaotropic agents are guanidine salts (e.g., guanidine hydrochloride and guanidine carbonate), urea, polysorbates, sodium benzoate, vanillin, o-cresol, phenol, propanol, formamide, ethanol, fructose, ammonium sulfate, ammonium chloride, ammonium nitrate, ammonium phosphate, potassium sulfate, potassium chloride, potassium iodide, potassium nitrate, potassium phosphate, sodium sulfate, sodium chloride, sodium bromide, sodium nitrate, sodium phosphate, guanidine thiocyanate, xylose, glycerol, benzyl alcohol, ethyl acetate, Triton X-100, ethyl acetate, cetyltrimethylammonium halide, acetone, sodium dodecyl sulfate (SDS), hydrochloric acid, sulfuric acid, polyethylene glycol, glutaraldehyde, and combinations thereof.

[0037] Any amount of chaotropic agent may be used. It may be preferred to denature the protein with the chaotropic agent such that 20 to 100 wt %, preferably 40 to 100 wt %, more preferably 60 to 100 wt %, and most preferably 90 to 100 wt % of the protein used in the preparation of the microcapsules is denatured.

[0038] The proteins used in the microcapsules can also be derivatized or modified (e.g., derivatized or chemically modified). For example, the proteins can be modified by covalently attaching sugars, lipids, cofactors, peptides, or other chemical groups including phosphates, acetates, methyl groups, and other natural or non-natural molecules.

[0039] The most preferred vegetable protein is pea protein.

[0040] Polysaccharides are a type of carbohydrates comprising multiple monosaccharide units. "Polysaccharides" as used herein refers to natural polysaccharides, polysaccharide derivatives and / or modified polysaccharides.

[0041] The polysaccharides used are selected from pectin (e.g. from various sources such as citrus, beet or apple), cellulose (natural or chemically modified, such as hydroxyethylcellulose), xanthan gum, konjac gum, xyloglucan, guar gum, tara gum, locust bean gum, inulin, curdlan gum, diutan gum, alginates, gellan gum and carrageenan.

[0042] Particularly preferred polysaccharides include: alginate, gellan gum and carrageenan.

[0043] The polysaccharides used in the microcapsules can also be derivatized or modified (e.g., derivatized or chemically modified). For example, proteins can be modified by covalently attaching sugars, lipids, cofactors, peptides, or other chemical groups (including phosphates, acetates, methyl groups, and other natural or non-natural molecules). Examples of suitable polysaccharide derivatives include: glycolic acid starch, carboxymethyl starch, hydroxyalkyl cellulose, and cross-linked modified cellulose.

[0044] The microcapsules preferably comprise 0.1 to 90% by weight of microcapsule shell, preferably 1 to 80% by weight, more preferably 2 to 70% by weight of microcapsule shell, based on the weight of the microcapsule. Preferably, this content of shell material is calculated solely from the content of protein and polysaccharide based on the weight of the microcapsule.

[0045] The microcapsule wall polymers described herein are preferably cross-linked, however the method of preparing the microcapsules does not involve chemical covalent cross-linking.

[0046] Preferably, the method is selected from ionic cross-linking, charged polymer cross-linking or hydrogen bonding, more preferably ionic cross-linking.

[0047] Suitable crosslinking methods include: ionic crosslinking, charged polymer crosslinking or hydrogen bonding, and internal crosslinking within the microcapsule wall polymer structure (including the formation of coacervates). Preferably, the method involves ionic crosslinking, such as salt bridge crosslinking. When a crosslinking agent such as an ionic crosslinking agent is used, the crosslinking agent is preferably present at a level of 0.1 wt% to 10 wt% based on the weight of the microcapsule.

[0048] The crosslinking agent suitable for the present invention is an ionic crosslinking agent. An ionic crosslinking agent is a multivalent ion that can form a salt bridge with a functional group of a protein or polysaccharide polymer. Suitable ionic crosslinking agents include calcium, copper, aluminum, magnesium, strontium, barium, zinc, tin, organic cations, poly(amino acids), poly(ethylene imine), poly(vinyl amine), poly(allyl amine) and polysaccharides, and the multivalent anion is selected from dicarboxylic acids, sulfate ions, carbonate ions, poly(acrylic acid), poly(methacrylic acid), copolymers of acrylic acid or methacrylic acid, sulfonated poly(styrene) and poly(styrene) with carboxylic acid groups and mixtures thereof. Particularly preferred are calcium salts, magnesium salts, sodium salts, potassium salts, strontium salts, barium salts, zinc salts.

[0049] Internal crosslinking is crosslinking between microcapsule wall polymers without the use of a crosslinking agent. Internal crosslinking can be crosslinking with the same polymer (i.e., a polymer with both positive and negative charges) or between two different polymers forming the microcapsule wall. When two different polymers with opposite charges are used, this is referred to as a coacervate formed by coacervation.

[0050] Preferably, the coacervate is formed between a first protein or polysaccharide having one charge and a second protein or polysaccharide having the opposite charge. The ratio between the polymer having a positive charge and the polymer having a negative charge is preferably 10 / 0.1 to 0.1 / 10, more preferably 10 / 1 to 1 / 10, and most preferably 6 / 1 to 1 / 6.

[0051] An example of a protein having a positive charge may be gelatin, and a protein or polysaccharide having a negative charge may be selected from gum arabic, xanthan gum, alginate, pectinate, carrageenan, polyacrylic acid and methacrylic acid, xanthan gum and vegetable gums and / or mixtures thereof.

[0052] Internally cross-linked microcapsules, ie, microcapsules having electrostatic interactions between positive and negative monomers within the microcapsule wall polymer, can be further cross-linked or "hardened" using salt bridges as described above.

[0053] The microcapsules may optionally contain further crosslinking agents. The further crosslinking agents may be selected from transglutaminases, peroxidases, secondary plant substances (selected from polyphenols, in particular tannins, gallic acid, ferulic acid, hesperidin, cinnamaldehyde, vanillin, carvacrol) and mixtures of two or more of the aforementioned crosslinking agents.

[0054] Microcapsule core material

[0055] The core material is selected from spices.

[0056] The core may also be referred to as the internal phase. The core of the microcapsule comprises the active material and optionally also a solvent and / or a cross-linking agent as described above. The core is preferably non-aqueous.

[0057] The microcapsules encapsulate the fragrance in a core (ie the core material is wholly or partly the fragrance). Preferably, the fragrance is biodegradable, wherein the biodegradability of fragrance is tested according to OECD standard 301F.

[0058] The inner non-aqueous phase may preferably contain 20-80 wt %, preferably 25-75 wt %, even more preferably 33-50 wt % of the active substance to be encapsulated, and preferably 0.1-5 wt %, preferably 0.15-3.5 wt %, even more preferably 0.5-2.5 wt % of the crosslinker and the rest of the composition solvent.

[0059] The beneficial agent may be dissolved in a solvent. Examples of suitable solvents include vegetable oils, glycerides, esters of fatty acids and branched alcohols, hydrocarbons, and the like. Specific examples include: diethyl phthalate, isopropyl myristate, (rosin resin, available from Eastman), benzyl benzoate, ethyl citrate, limonene or other terpenes, triacetin or isoparaffin, preferably Benzyl benzoate, limonene or other terpenes, isoparaffins or combinations thereof. Preferably, if present, the solvent is 0 to 30% by weight of the active material, more preferably 0 to 20% by weight of the active material, most preferably 0 to 10% by weight of the active material.

[0060] Most preferably, the microcapsule core material comprises a flavor. Flavor components are well known in the art. Useful flavor components may include materials of natural and synthetic origin. They include single compounds and mixtures. Specific examples of such components can be found in the current literature, for example, Fenaroli's Handbook of Flavor Ingredients, 1975, CRC Press; Synthetic Food Adjuncts, 1947, MB Jacobs, Van Nostrand ed.; or Perfume and Flavor Chemicals by S. Arctander 1969, Montclair, NJ (USA). These substances are well known to those skilled in the art of flavoring, seasoning and / or perfuming consumer products.

[0061] Particularly preferred perfume components are fragrance-releasing perfume components and substantive perfume components. The fragrance-releasing perfume component is defined by a boiling point of less than 250°C and a LogP of greater than 2.5. Preferably, the encapsulated perfume composition comprises at least 20% by weight of fragrance-releasing perfume ingredients, more preferably at least 30% by weight, and most preferably at least 40% by weight of fragrance-releasing perfume ingredients. The substantive perfume component is defined by a boiling point of greater than 250°C and a LogP of greater than 2.5. Preferably, the encapsulated perfume composition comprises at least 10% by weight of substantive perfume ingredients, more preferably at least 20% by weight, and most preferably at least 30% by weight of substantive perfume ingredients. The boiling point is measured at standard pressure (760 mmHg). Preferably, the perfume composition will comprise a mixture of fragrance-releasing and substantive perfume components. The perfume composition may comprise other perfume components.

[0062] It is common for multiple perfume components to be present in the microcapsules. In the composition used in the present invention, it is envisaged that three or more different perfume components, preferably four or more different perfume components, more preferably five or more different perfume components, and most preferably six or more different perfume components are present in the microcapsules. Up to 300 perfume components can be used.

[0063] Preferably, the amount of encapsulated active substance is 5 to 95 wt %, preferably 10 to 90 wt %, more preferably 15 to 85 wt %, and most preferably 20 to 80 wt % of the weight of the microcapsule.

[0064] Deposition aids

[0065] Preferably, the microcapsules further comprise one or more deposition aids attached to the microcapsule shell.

[0066] If used, the deposition aid is preferably selected from trimethylammonium, methacrylamidopropyltrimethylammonium, acrylamidopropyltrimethylammonium, acrylamide, acrylic acid, dimethylammonium, xylose, galactose, hydroxypropylated glucose, chitosan, hydroxyethylated glucose, hydroxymethylated glucose, vinylamine, ethyleneimine, functionalized branched polyethyleneimine, vinylformamide, vinylpyrrolidone, caprolactone, catechol, vinyl alcohol, chitosan, polyquaternium-4, polyquaternium-5, polyquaternium-6, polyquaternium-7, polyquaternium-10, polyquaternium-11, polyquaternium-16, polyquaternium-22, polyquaternium-24, polyquaternium-28, polyquaternium-37, polyquaternium-39, polyquaternium-44, polyquaternium-46, polyquaternium-47, polyquaternium-53, polyquaternium-54, polyquaternium-55, polyquaternium-56, polyquaternium-57, polyquaternium-58, polyquaternium-59, polyquaternium-60, polyquaternium-61, polyquaternium-62, polyquaternium-63, polyquaternium-64, polyquaternium-65, polyquaternium-66, polyquaternium-67, polyquaternium-68, polyquaternium-69, polyquaternium-70, polyquaternium-71, polyquaternium-72, polyquaternium-73, polyquaternium-74, polyquaternium-75, polyquaternium-76, polyquaternium-77, polyquaternium-78, polyquaternium-79, polyquaternium-80, polyquaternium-81, polyquaternium-82, polyquaternium-83, polyquaternium-84, polyquaternium-85, polyqua -55, polyquaternium-67, polyquaternium-68, polyquaternium-69, polyquaternium-73, polyquaternium-74, polyquaternium-77, polyquaternium-78, polyquaternium-79, polyquaternium-80, polyquaternium-81, polyquaternium-82, polyquaternium-86, polyquaternium-88, polyquaternium-101, polyquaternium-79 hydrolyzed keratin, polyvinylamine, polyethyleneimine, copolymers of vinylamine and vinylformamide, copolymers of acrylamide and 3-methacryloylaminopropyltrimethylammonium, 3-acrylamidopropyltrimethylammonium polymer or its copolymer, diallyldimethylammonium chloride polymer and its copolymer, polysaccharides having sugar units functionalized with hydroxypropyltrimethylammonium, ethyltrimethylammonium chloride methacrylate and hydrolyzed wheat protein copolymer, alkyl-methylammonium hydroxypropyl hydrolyzed protein and combinations thereof.

[0067] More preferably, any deposition aid used is biodegradable according to OECD standard 30 IF.

[0068] Microcapsule composition

[0069] As used herein, the term "microcapsule" refers to capsules preferably having a median particle size d(50) of 0.1 to 1000 microns, preferably 0.1 to 300 microns, more preferably 1 to 200 microns, such as 20 to 200 microns.

[0070] The median particle size d(50) is determined by laser diffraction analysis, for example by using a Horiba LA940 or Mastersizer 3000 from Malvern using the "Mie scattering theory" evaluation. The median value is defined as the value where half of the population is above this point and half is below this point. For particle size distributions, the median value is called "d(50)" or "D50".

[0071] Microcapsules can be positively or negatively charged, and their zeta potential is preferably -200mV to +200mV, more preferably 25mV to 200mV, and most preferably 40mV to 100mV. Preferably, the microcapsules are positively charged. Zeta potential is a measure of the electromotive potential in the microcapsules. From a theoretical point of view, the zeta potential is the potential difference between the aqueous phase (i.e., the dispersion medium) and the fixed layer of water attached to the surface of the microcapsule. The zeta potential can be calculated using theoretical models and experimentally determined electrophoretic mobility or dynamic electrophoretic mobility. Zeta potential is conventionally measured by methods such as microelectrophoresis, or electrophoretic light scattering, or electroacoustic phenomena. For a more detailed discussion of zeta potential measurement, see Dukhin and Goetz, "Ultrasound for characterizing colloids", Elsevier, 2002.

[0072] The microcapsule composition of the present invention may be a slurry containing a solvent, preferably water. The microcapsules are preferably present in the slurry at 0.1% to 80% by weight, more preferably 1% to 65% by weight, and most preferably 5% to 45% by weight of the weight of the microcapsule composition. The slurry may contain a thickening or suspending agent, such as xanthan gum, carboxymethyl cellulose (CMC), microcrystalline cellulose (MCC) or guar gum.

[0073] Alternatively, the microcapsule composition of the present invention may also be dried into a solid form, such as by spray drying, heat drying, and belt drying.

[0074] The microcapsule composition can be purified by washing the capsule slurry with water until a neutral pH (pH of 6 to 8) is reached. For the purposes of the present invention, the capsule suspension can be washed using any conventional method, including the use of a separatory funnel, filter paper, centrifugation, and the like. The capsule suspension can be washed once, twice, three times, four times, five times, six times, or more times until a neutral pH, such as pH 6-8 and 6.5-7.5, is reached. The pH of the purified capsules can be determined using any conventional method, including but not limited to pH test paper, pH indicator, or pH meter. In certain embodiments of the present invention, the purification of the capsules includes an additional step of adding a salt to the capsule suspension prior to the step of washing the capsule suspension with water. Exemplary salts used in this step of the present invention include but are not limited to sodium chloride, potassium chloride, or bisulfite.

[0075] Preparation of microcapsules

[0076] When preparing microcapsules, the polymer can be provided in a solvent. Suitable solvents for preparing the microcapsule wall include water or a mixture of water and at least one water-miscible organic solvent. Suitable organic solvents include glycerol, 1,2-propylene glycol, 1,3-propylene glycol, ethylene glycol, diethylene glycol, triethylene glycol and other analogs. Preferably, the solvent is water.

[0077] Stabilizers may also be present. Stabilizers may be selected from acrylic copolymers (preferably with sulfonate groups), copolymers of acrylamide and acrylic acid, copolymers of alkyl acrylates and N-vinyl pyrrolidone, for example K15, K30 or K90 (BASF); sodium polycarboxylate, sodium polystyrene sulfonate, vinyl and methyl vinyl ether-maleic anhydride copolymers and ethylene, isobutylene or styrene-maleic anhydride copolymers, microcrystalline cellulose (which can be obtained, for example, under the name commercially available), diutan gum, xanthan gum or carboxymethyl cellulose.

[0078] The crosslinking of the microcapsules preferably involves a catalyst. The catalyst may be present in the microcapsule core active material or added separately to the oil-in-water emulsion or dispersion. A preferred catalyst for forming the microcapsules according to the invention is diazabicyclo[2.2.2]octane (DABCO), also known as triethylenediamine (TEDA). Also suitable are bismuth- or tin-based catalysts, transglutaminases, peroxidases, secondary plant compounds selected from polyphenols (particularly tannins), gallic acid, ferulic acid, hesperidin, cinnamaldehyde, vanillin, carvacrol and mixtures thereof.

[0079] Alternatively or additionally, the formation of the microcapsules may be catalysed by heating the oil-in-water emulsion or dispersion, for example to a temperature in the range of 60°C to 90°C.

[0080] A variety of suitable production methods can be implemented to produce microcapsules suitable for use in the present invention.

[0081] One suitable method is interfacial polymerization. An example of interfacial polymerization includes the following steps:

[0082] (i) providing a microcapsule core material comprising at least one first crosslinking agent, wherein the crosslinking agent is substantially dissolved with the core material. This is the oil phase. A non-aqueous solvent may optionally be present;

[0083] (ii) providing a microcapsule wall material comprising at least one protein and at least one polysaccharide. This is the aqueous phase. An aqueous solvent may optionally be present;

[0084] (iii) emulsifying or dispersing the microcapsule core material with the microcapsule wall material. The preferred ratio is from 70:30 to 60:40, preferably in the range of 30:70-60:40. Optionally, an emulsifier may be used. Emulsification may be achieved by using high-speed mixing. After completion of this stage, there is an oil-in-water emulsion or dispersion in which the inner phase with the active substance to be encapsulated is finely emulsified or dispersed in the outer wall material phase in the form of droplets;

[0085] (iv) optionally performing a first crosslinking by adding at least one catalyst to obtain a microcapsule slurry, optionally adding further protein and / or polysaccharide polymers;

[0086] (v) curing the microcapsule slurry, preferably at a temperature of at least 60° C., preferably for at least 30 minutes, and then cooling;

[0087] (vi) optionally drying, using methods such as spray drying, filtration or freeze drying.

[0088] An alternative method includes 3D printing of microcapsules. Both the microcapsule shell and the microcapsule core can be printed using a printing system. See WO 2016172699A1. The printing step typically involves depositing the active material and the microcapsule shell material in a layer-by-layer manner, preferably by separate print heads.

[0089] use

[0090] Fabric care can be defined by various parameters, in particular fabric handle, softness and resilience. These are measurements that decrease as fabrics are damaged. In other words, fabric care can be considered as damage prevention or maintenance of fabrics. Fabric handle is defined as the estimated quality of a fabric evaluated when a consumer touches the fabric. Important components of fabric handle include smoothness, compressibility and elasticity of the textile sample. The compositions described herein can also provide improved softening and / or resilience to fabrics treated with the compositions. Resilience is the ability of a fiber to rebound to its natural position after being folded, wrinkled or deformed. Improvements in fabric handle, resilience or softening can be measured using sensory evaluation. Alternatively, machine measurements can be used. Suitable machines for measuring relative handle values, resilience or softness are provided by Nu Cybertek, Inc. The improvement in fabric hand can be measured using AATCC TM202-2012 (2020), Relative Hand Value of Textiles: Instrumental Method.

[0091] Example

[0092] Example 1

[0093] Preparation of microcapsules

[0094] The following microcapsules were used to evaluate the effects of the compositions described herein:

[0095] Microcapsule A-Melamine formaldehyde microcapsule

[0096] Microencapsulated B-pea protein with polyisocyanate crosslinking (poly[(phenylisocyanate-co-formaldehyde])

[0097] Microcapsule 1-pea protein and sodium alginate mixed with salt cross-linking

[0098] The same type of fragrance composition was used in all microcapsules.

[0099] Microcapsules A were prepared by dispersing formalin in water and adjusting the pH to 9. Melamine and 0.28 g of sodium chloride were added. The mixture was heated to about 65°C for one hour. Additional water was added and the solution was heated to about 75°C. The pH was adjusted to 4. Fragrance was then added under homogenization. Heating and stirring were continued for 3 hours. The mixture was then cooled and the pH was adjusted to 7.

[0100] Table 1: Microcapsule A composition

[0101]

[0102] Microcapsule B was prepared as follows: First, an oil phase was prepared by mixing 23.2 g of a model fragrance and 4.8 g of caprylic / capric triglyceride, 0.38 g of benzyl benzoate, and 0.38 g of an aromatic polyisocyanate. In a separate beaker, an aqueous solution was obtained by mixing 1.182 g of pea protein isolate in 170 g of water. The oil phase was then emulsified into the water phase using an ultra turrax mixer at a shear rate of 5000 revolutions per minute (RPM) to form an oil-in-water emulsion. The oil-in-water emulsion was then cured at 55°C for 2 hours.

[0103] Table 2: Microcapsule B composition

[0104]

[0105] Microcapsules B are covalently crosslinked polyisocyanate microcapsules as described in WO2020 / 131879A1.

[0106] Microcapsule 1 (according to the invention) was prepared as follows: A pea protein solution was prepared in demineralized water and the pH was adjusted to pH 9 using a few drops of sodium carbonate solution. It was heated to 85°C and mixed on a tornado mixer at 300 RPM for 2 hours. After 2 hours, the pH was lowered to pH 7 with a few drops of 2M HCl solution and 1.5 g of sodium alginate was added.

[0107] It was further mixed at 300 RPM for 90 minutes until homogenized and then left overnight to cool. The next day after cooling, 22.5 g of fragrance oil was added and mixed at 300 RPM for 1 hour. The prepolymer mixture was then added to 80 ml of a solution containing Tween 80, calcium chloride and deionized water at different concentrations. The solution was homogenized to produce a suspension.

[0108] Table 2: Microcapsule 1 composition

[0109]

[0110] Preparation of fabric conditioner

[0111] Table 4: Fabric Conditioner Composition

[0112]

[0113] Fabric softening actives 1 -Dialkoxyethyl hydroxyethyl methyl ammonium methyl sulfate

[0114] The fabric conditioner is prepared by melting the fabric softening active at about 65°C. The water is heated to about 40°C. The trace materials and the fabric softening active are added with stirring. The water is then cooled slightly. The composition is then cooled to room temperature. The perfume microcapsules are then added to the composition. The 2 wt% is based on the weight of the microcapsules.

[0115] Washing method

[0116] Washing was performed in a terg-o-tometer jar. 0.5 ml of the test fabric conditioner composition and 1 L of water were added to the tergo jar followed by 40 g of knitted cotton. The test monitor was rinsed in the liquid for 10 minutes and spun for 30 seconds. The fabric was then hung to dry at ambient conditions.

[0117] analyze

[0118] The properties of the fabrics were evaluated by NUCybertek* using a Phabrometer.

[0119] 11.3 cm discs were cut from the test fabrics. Fabric measurements were made using a Phabrometer and in accordance with AATCC Standard TM202.

[0120] Ten replicates were measured for each fabric and the results were averaged.

[0121] Table 5: Results

[0122] Microcapsule Type Relative feel value Microcapsule A 1.4682 Microcapsule B 1.5633 Microcapsule 1 1.9391

[0123] A higher score indicates an improved relative feel value. Compared to conventional melamine formaldehyde microcapsules and covalently crosslinked polyisocyanate microcapsules as described in WO 2020 / 131879 A1, the microcapsules according to the present invention provide improved relative feel values.

[0124] Example 2

[0125] Microcapsules B and 1 were prepared as in Example 1.

[0126] Preparation of fabric conditioner

[0127] Table 6: Fabric Conditioner Composition

[0128]

[0129] Fabric softening actives 1 -Dialkoxyethyl hydroxyethyl methyl ammonium methyl sulfate

[0130] The fabric conditioner is prepared by melting the fabric softening active at about 65°C. The water is heated to about 40°C. The trace materials and the fabric softening active are added with stirring. The water is then cooled slightly. The composition is then cooled to room temperature. The perfume microcapsules are then added to the composition. The weight % is based on the weight of the microcapsules.

[0131] Washing method

[0132] Washing was done in a tergo jar. 0.5 ml of the test fabric conditioner composition and 1 L of water were added to a tergo jar followed by 40 g of knitted cotton. The test monitor was rinsed in the liquid for 10 minutes and spun for 30 seconds. The fabric was then hung to dry at ambient conditions.

[0133] analyze

[0134] The properties of the fabrics were evaluated using a Phabrometer by NUCybertek*. 11.3 cm discs were cut from the test fabrics. Fabric measurements were performed using a Phabrometer and according to AATCC Standard TM202.

[0135] Ten replicates were measured for each fabric and the results were averaged.

[0136] Table 7: Results

[0137] Microcapsule Type Overhang Resilience Microcapsule B 20.85 60.58 Microcapsule 1 18.68 56.96

[0138] Lower values ​​indicate improved fabric properties. Fabrics treated with the product comprising microcapsules with ionic crosslinking agents have better fabric shape and drape.

[0139] Example 3

[0140] Further microcapsules were prepared according to the following exemplary method with any minor deviations from the general method indicated:-

[0141] General approach

[0142] A pea protein solution was prepared in demineralized water and the pH was adjusted to pH 9 using a few drops of sodium carbonate solution. It was heated to 85°C and mixed at 300 RPM for 2 hours on a tornado mixer. After 2 hours, the pH was lowered to pH 7 with a few drops of 2M HCl solution and 1 g of polysaccharide was added.

[0143] It was further mixed at 300 RPM for 90 minutes until uniform and then left overnight to cool. The next day after cooling, 15 g of fragrance oil was added and mixed at 300 RPM for 1 hour. The prepolymer mixture was then added to a 40 ml solution containing Tween 80, calcium chloride and deionized water at different concentrations. The solution was homogenized to produce a suspension.

[0144] Microcapsules 2 were dispersed in 80 g of demineralized water containing 2% emulsifier (Tween 80) and 2% CaCl2.2H2O.

[0145] Homogenization rate 20000RPM, heating temperature 85℃, 2 hours

[0146] Table 8: Microcapsule 2 composition

[0147]

[0148] Microcapsules 3 were dispersed in 80 g of demineralized water containing 2% emulsifier (Tween 80) and 2% CaCl2.2H2O.

[0149] Homogenization rate 20000RPM, heating temperature 85C, 2 hours

[0150] Table 9: Microcapsule 3 composition

[0151]

[0152] Microcapsules 4 were dispersed in 80 g of demineralized water containing 2% emulsifier (Tween 80) and 2% CaCl2.2H2O.

[0153] Homogenization rate 20000RPM, heating temperature 85℃, 2 hours

[0154] Table 10: Microcapsule 4 composition

[0155]

[0156] Microcapsules 5 were dispersed in 80 g of demineralized water containing 2% emulsifier (Tween 80) and 2% CaCl2.2H2O.

[0157] Homogenization rate 20000RPM, heating temperature 85℃, 2 hours

[0158] Table 11: Microcapsule 5 composition

[0159]

[0160]

[0161] Microcapsules 6 were dispersed in 80 g of demineralized water containing 2% emulsifier (Tween 80) and 2% CaCl2.2H2O.

[0162] Homogenization rate 20000RPM, heating temperature 85℃, 2 hours

[0163] Table 12: Microcapsule 6 composition

[0164]

[0165] Microcapsules 7 were dispersed in 300 g of demineralized water containing 1% emulsifier (Tween 80) and 2% CaCl2.2H2O.

[0166] Homogenization rate 20000RPM, heating temperature 85℃, 2 hours

[0167] Table 13: Microcapsule 7 composition

[0168]

[0169] Microcapsules 8 were dispersed in 300 g of demineralized water containing 1.5% emulsifier (Tween 80) and 2% CaCl2.2H2O.

[0170] Homogenization rate 20000RPM, heating temperature 85℃, 2 hours

[0171] Table 14: Microcapsule 8 composition

[0172]

[0173]

[0174] Microcapsules 9 were dispersed in 300 g of demineralized water containing 1.5% emulsifier (Tween 80) and 2% CaCl2.2H2O.

[0175] Homogenization rate 20000RPM, heating temperature 85℃, 2 hours

[0176] Table 15: Microcapsule 9 composition

[0177]

[0178] Microcapsules 10 were dispersed in 300 g of demineralized water containing 1% emulsifier (Tween 80) and 2% CaCl2.2H2O.

[0179] Homogenization rate 20000RPM, heating temperature 85C, 2 hours

[0180] Table 16: Microcapsule 10 composition

[0181]

[0182] Microcapsules 11 were dispersed in 150 g of demineralized water containing 2% emulsifier (Tween 80) and 2% CaCl2.2H2O.

[0183] Homogenization rate 20000RPM, heating temperature 85C, 2 hours

[0184] Table 17: Microcapsule 11 composition

[0185]

Claims

1. A microcapsule, wherein the microcapsule has a core and a shell; the core comprises a core material selected from spices; the shell comprises a plant protein and a polysaccharide, wherein the polysaccharide is selected from: pectin, natural or chemically modified cellulose, xanthan gum, konjac gum, xyloglucan, guar gum, tara gum, locust bean gum, inulin, curdlan gum, diutan gum, alginate, gellan gum and carrageenan.

2. The microcapsule according to claim 1, wherein the microcapsule is biodegradable.

3. The microcapsule according to claim 1 or claim 2, wherein the microcapsule encapsulates a biodegradable fragrance.

4. Microcapsules according to any one of the preceding claims, wherein the protein is pea protein.

5. The microcapsule according to any one of the preceding claims, wherein the polysaccharide is selected from the group consisting of alginate, gellan gum, carrageenan, more preferably the polysaccharide is alginate.

6. Microcapsule according to any one of the preceding claims, wherein the microcapsule comprises 1 to 80 wt. %, preferably 2 to 70 wt. % of shell material.

7. The microcapsule according to any one of the preceding claims, wherein the microcapsule further comprises a deposition aid attached to the shell of the microcapsule, preferably the deposition aid is selected from trimethylammonium, methacrylamidopropyltrimethylammonium, acrylamidopropyltrimethylammonium, acrylamide, acrylic acid, dimethylammonium, xylose, galactose, hydroxypropylated glucose, chitosan, hydroxyethylated glucose, hydroxymethylated glucose, vinylamine, ethyleneimine, functionalized branched polyethyleneimine, vinylformamide, vinylpyrrolidone, caprolactone, catechol, vinyl alcohol, chitosan, polyquaternium-4, polyquaternium-5, polyquaternium-6, polyquaternium-7, polyquaternium-10, polyquaternium-11, polyquaternium-16, polyquaternium-22, polyquaternium-24, polyquaternium-28, polyquaternium-37, polyquaternium-39, polyquaternium-44, polyquaternium-46, polyquaternium Salt-47, Polyquaternium-53, Polyquaternium-55, Polyquaternium-67, Polyquaternium-68, Polyquaternium-69, Polyquaternium-73, Polyquaternium-74, Polyquaternium-77, Polyquaternium-78, Polyquaternium-79, Polyquaternium-80, Polyquaternium-81, Polyquaternium-82, Polyquaternium-86, Polyquaternium-88, Polyquaternium-101, Polyquaternium-79 Hydrolyzed keratin, polyvinylamine , polyethyleneimine, copolymers of vinylamine and vinylformamide, copolymers of acrylamide and 3-methacrylamidopropyltrimethylammonium, 3-acrylamidopropyltrimethylammonium polymer or its copolymer, diallyldimethylammonium chloride polymer and its copolymer, polysaccharides having sugar units functionalized with hydroxypropyltrimethylammonium, ethyltrimethylammonium chloride methacrylate and hydrolyzed wheat protein copolymers, alkyl-methylammonium hydroxypropyl hydrolyzed protein and combinations thereof.

8. A method for preparing microcapsules according to any one of claims 1 to 7, wherein the method does not involve chemical covalent crosslinking, preferably the method is selected from ionic crosslinking, charged polymer crosslinking or hydrogen bonding, more preferably ionic crosslinking.

9. The method for preparing microcapsules according to claim 9, wherein the method is selected from ionic crosslinking, charged polymer crosslinking or hydrogen bonding, preferably ionic crosslinking.